RxNorm Semantic Concepts Index - 298
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "298".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 29818 | N-Methylglutamate synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29818 | N-Methylglutamate synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29818 | N-Methylglutamate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29824 | Beta-methylaspartase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29824 | Beta-methylaspartase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29824 | Beta-methylaspartase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29825 | Glutamate mutase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29825 | Glutamate mutase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29825 | Glutamate mutase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29829 | Methylbenzethonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 29829 | Methylbenzethonium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2983 | Cyclofenil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2983 | Cyclofenil | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2983 | Cyclofenil | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2983 | Cyclofenil | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2983 | Cyclofenil | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29836 | 3-methylcrotonyl-CoA carboxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29836 | 3-methylcrotonyl-CoA carboxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29836 | 3-methylcrotonyl-CoA carboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29836 | 3-methylcrotonyl-CoA carboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2984 | Cyclogyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 29844 | methylene diphosphonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 29849 | Methylene tetrahydrofolate reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29849 | Methylene tetrahydrofolate reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29849 | Methylene tetrahydrofolate reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29849 | Methylene tetrahydrofolate reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29854 | Methylenetetrahydromethanopterin dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29854 | Methylenetetrahydromethanopterin dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 298665 | nepafenac | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 298665 | nepafenac | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 298665 | nepafenac | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 298665 | nepafenac | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 298665 | nepafenac | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29868 | 3-methylglutaconyl-CoA hydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29868 | 3-methylglutaconyl-CoA hydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29868 | 3-methylglutaconyl-CoA hydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29868 | 3-methylglutaconyl-CoA hydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29868 | 3-methylglutaconyl-CoA hydratase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29872 | Methylglyoxal dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29872 | Methylglyoxal dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29872 | Methylglyoxal dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29872 | Methylglyoxal dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29872 | Methylglyoxal dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29873 | Methylglyoxal synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29873 | Methylglyoxal synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29876 | Methylhydroxy-pyridinecarboxylate oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29876 | Methylhydroxy-pyridinecarboxylate oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29876 | Methylhydroxy-pyridinecarboxylate oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29882 | Methylmalonate-semialdehyde dehydrogenase (acylating) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29882 | Methylmalonate-semialdehyde dehydrogenase (acylating) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29884 | Methylmalonyl-coenzyme A carboxyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29884 | Methylmalonyl-coenzyme A carboxyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29884 | Methylmalonyl-coenzyme A carboxyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29886 | Methylmalonyl-CoA racemase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29886 | Methylmalonyl-CoA racemase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29886 | Methylmalonyl-CoA racemase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29886 | Methylmalonyl-CoA racemase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 298869 | eplerenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 298869 | eplerenone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 298869 | eplerenone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 298869 | eplerenone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 298869 | eplerenone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29897 | methyl methacrylate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29897 | methyl methacrylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 29897 | methyl methacrylate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29897 | methyl methacrylate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29897 | methyl methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 29897 | methyl methacrylate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 298983 | ponazuril | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 29899 | methylnaltrexone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 29899 | methylnaltrexone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29899 | methylnaltrexone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29899 | methylnaltrexone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29899 | methylnaltrexone | Full form of descriptor (FN) | YES |